Approval · Notice of Compliance 7862 · 2006
CEREZYME: Notice of Compliance 7862
Issued March 31, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7862
- Date
- March 31, 2006
- Company
- Genzyme Canada Inc
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Expand indication to include type 3 gaucher disease
- Therapeutic class
- Enzyme replacement therapy
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CEREZYME | Not yet assigned | — |
Medicinal ingredients
- IMIGLUCERASE 200 UNIT per VIAL
- IMIGLUCERASE 400 UNIT per VIAL